A detailed history of Bleakley Financial Group, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 13,312 shares of TERN stock, worth $77,209. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,312
Previous 10,561 26.05%
Holding current value
$77,209
Previous $71.9 Million 54.37%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$6.49 - $10.8 $17,853 - $29,710
2,751 Added 26.05%
13,312 $111 Million
Q2 2024

Aug 12, 2024

BUY
$4.54 - $8.2 $47,946 - $86,600
10,561 New
10,561 $71.9 Million
Q4 2023

Jan 25, 2024

BUY
$3.37 - $6.86 $35,223 - $71,700
10,452 New
10,452 $67.8 Million

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $218M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.